TNFSF10 and triple-negative breast carcinoma: PVX-delivered TRAIL outperformed soluble TRAIL in activating caspase-mediated apoptosis and in delaying tumor growth in an athymic nude mouse model bearing human triple-negative breast cancer xenografts in vivo.